檢索結果 - Mazyar Shadman
- Showing 1 - 20 results of 48
- Go to Next Page
-
1
-
2
-
3
P621: REAL-WORLD DOSING PATTERNS AND TIME TO NEXT TREATMENT FOR PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL WITH OR WITHOUT IBRUTINIB DOSE REDUCTION FOLLOWING AN ADVERSE EVENT 由 Mazyar Shadman, Bhavini Srivastava, Sima Patel, Chadi Saifan, Monika Salkar, Bruno Emond, Priyanka Gogna, Ameur Manceur, Marie-Helene Lafeuille, Deborah Stephens
發表在 HemaSphere (2023-08-01)獲取全文
Article -
4
-
5
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic 由 Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, Michael Hallek, Peter Hillmen, Anthony Mato, Emili Montserrat, Paolo Ghia
發表在 HemaSphere (2020-08-01)獲取全文
Article -
6
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial 由 Alexey V. Danilov, Hongli Li, Mazyar Shadman, Lisa Rimsza, Ahmad Zebari, Sonali M. Smith, Michael LeBlanc, Jonathan W. Friedberg, Christopher Carlson, Joo Y. Song
發表在 Haematologica (2025-07-01)獲取全文
Article -
7
Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis 由 Mazyar Shadman, Jennifer R. Brown, Leyla Mohseninejad, Keri Yang, Heather Burnett, Binod Neupane, Rhys Williams, Nicole Lamanna, Susan M. O'Brien, Alessandra Tedeschi, Constantine S. Tam
發表在 Blood Advances (2025-06-01)獲取全文
Article -
8
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC) 由 Mazyar Shadman, Jennifer R. Brown, Rhys Williams, Leyla Mohseninejad, Keri Yang, Pal Rakonczai, Nicole Lamanna, Sheng Xu, Aileen Cleary Cohen, Susan M. O’Brien, Alessandra Tedeschi, Constantine S. Tam
發表在 Therapeutic Advances in Medical Oncology (2025-07-01)獲取全文
Article -
9
P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL 由 Emily Liang, Alexandre Hirayama, Erik Kimble, Andrew Portuguese, Aya Albittar, Aude Chapuis, Mazyar Shadman, Brian Till, Ryan Cassaday, Filippo Milano, Hans-Peter Kiem, Camesron Turtle, David Maloney, Jordan Gauthier
發表在 HemaSphere (2023-08-01)獲取全文
Article -
10
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison 由 Mazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, Keri Yang, Nicole Lamanna, Sheng Xu, Aileen Cohen, Swetha Challagulla, Mei Xue, Rhys Williams, Susan M. O’Brien, Jennifer R. Brown, Constantine Tam
發表在 Blood Cancer Journal (2024-05-01)獲取全文
Article -
11
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB 由 Mazyar Shadman, Moshe Y. Levy, Ryan Porter, John M. Burke, Jennifer L. Cultrera, Jamal Misleh, Jeff Sharman, Syed F. Zafar, Kunthel By, Aileen Cohen, Rocco Crescenzo, Adam Idoine, Ian W. Flinn
發表在 HemaSphere (2023-08-01)獲取全文
Article -
12
Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study 由 Jennifer R. Brown, Jessica Li, Barbara F. Eichhorst, Nicole Lamanna, Susan M. O’Brien, Constantine S. Tam, Lugui Qiu, Ruiqi Huang, Yang Shi, Adam Idoine, Tommi Salmi, Aileen Cleary Cohen, Mazyar Shadman
發表在 Blood Advances (2025-04-01)獲取全文
Article -
13
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphoma 由 Lorenzo Iovino, Ningxin Ma, Mohamed A. Kharfan-Dabaja, Alex F. Herrera, Craig S. Sauter, Mehdi Hamadani, Peter A. Riedell, Ajay K. Gopal, Leona Holmberg, Qian Vicky Wu, Sonali M. Smith, Mazyar Shadman
發表在 Blood Neoplasia (2026-08-01)獲取全文
Article -
14
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma 由 John Sharp, Subodh Bhatta, Jennifer J. Huang, Colin J. Thomas, Omar Elghawy, Lindsey Fitzgerald, Daniel Reef, Andinet Teferra, Timothy J. Voorhees, Supriya Gupta, Natalie S. Grover, Stefan K. Barta, Mazyar Shadman, Narendranath Epperla
發表在 Blood Cancer Journal (2026-06-01)獲取全文
Article -
15
PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-... 由 Constantine Tam, Mazyar Shadman, Jeff Sharman, Gavin Cull, Tycel Phillips, Judith Trotman, Aileen Cohen, Heather Allewelt, Rocco Crescenzo, Richard Delarue, Heather Zhang, Bilal Tariq, Sri Sahasranaman, Ying C Ou, Ian W Flinn
發表在 HemaSphere (2023-08-01)獲取全文
Article -
16
Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results 由 Mazyar Shadman, John M. Burke, Jennifer Cultrera, Habte A. Yimer, Syed F. Zafar, Jamal Misleh, Subramanya S. Rao, Charles M. Farber, Aileen Cohen, Hui Yao, Adam Idoine, Qi An, Ian W. Flinn, Jeff P. Sharman
發表在 Blood Advances (2025-08-01)獲取全文
Article -
17
CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype 由 Dong Hoon Lee, Wei Sun, Si Liu, Sang Yun Lee, Damian J Green, Ryan S Basom, Francisco Cervantes-Contreras, Feinan Wu, Richa Rai, Hamid R Mirzaei, Shyril O’Steen, Mazyar Shadman, Brian G Till
發表在 Journal for ImmunoTherapy of Cancer (2023-11-01)獲取全文
Article -
18
Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large cli... 由 Jennifer R. Brown, Paolo Ghia, Wojciech Jurczak, Brad S. Kahl, Nicole Lamanna, Tadeusz Robak, Mazyar Shadman, Constantine S. Tam, Lugui Qiu, Jason Paik, Tommi Salmi, Liping Wang, Jun Zhang, Meng Zhang, Aileen Cohen, Han Ma, Alessandra Tedeschi
發表在 Haematologica (2024-02-01)獲取全文
Article -
19
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma 由 Andrew J. Portuguese, Emily C. Liang, Jennifer J. Huang, Yein Jeon, Danai Dima, Rahul Banerjee, Mary Kwok, Kara I. Cicero, Alexandre V. Hirayama, Ryan Basom, Christy Khouderchah, Mazyar Shadman, Lawrence Fong, Andrew J. Cowan, Jordan Gauthier
發表在 Haematologica (2025-06-01)獲取全文
Article -
20
Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies 由 David W. Woolston, Nathan D. Lee, Mazyar Shadman, Elena Latorre-Esteves, Xin Ray Tee, Jeanne Fredrickson, Brendan F. Kohrn, Chaitra Ujjani, Ashley Eckel, Brian Till, Min Fang, Jerald Radich, Ivana Bozic, Rosa Ana Risques, Cecilia C.S. Yeung
發表在 Haematologica (2023-09-01)獲取全文
Article
